Nakano, Yutaka
Endo, Yutaka
Kitago, Minoru
Nishiyama, Ryo
Yagi, Hiroshi
Abe, Yuta
Hasegawa, Yasushi
Hori, Shutaro
Tanaka, Masayuki
Shimane, Gaku
Soga, Shigeyoshi
Egawa, Tomohisa
Okuda, Shigeo
Kitagawa, Yuko
Article History
Received: 15 May 2022
Accepted: 26 April 2023
First Online: 2 May 2023
Declarations
:
: The protocol for this research project has been approved by a suitably constituted Ethics Committee of Keio University School of Medicine, and it conforms to the provisions of the Declaration of Helsinki, Committee of Keio University School of Medicine, Approval No. 20140389.
: Dr. Kitagawa reports grants and personal fees from ASAHI KASEI PHARMA CORPORATION; grants and personal fees from TAIHO PHARMACEUTICAL CO., Ltd.; grants and personal fees from CHUGAI PHARMACEUTICAL CO., Ltd.; grants and personal fees from EA Pharma Co., Ltd.; grants and personal fees from Yakult Honsha Co. Ltd.; grants and personal fees from Otsuka Pharmaceutical Co., Ltd.; grants from Takeda Pharmaceutical Co., Ltd.; grants and personal fees from Otsuka Pharmaceutical Factory Inc.; grants from KAKEN PHARMACEUTICAL CO., Ltd.; grants and personal fees from Astellas Pharma Inc.; grants from MEDICON INC.; grants and personal fees from DAINIPPON SUMITOMO PHARMA Co., Ltd.; grants and personal fees from Toyama Chemical Co., Ltd.; grants from Kyouwa Hakkou Kirin Co., Ltd.; grants and personal fees from ONO PHARMACEUTICAL CO., Ltd.; grants and personal fees from NIHON PHARMACEUTICAL CO., Ltd.; grants from TSUMURA & CO.; grants from FUJIFILM Toyama Chemical Co., Ltd.; grants from Nippon Covidien Inc.; grants from Eisai Co., Ltd.; grants from TEIJIN PHARMA LIMITED; and personal fees from SHIONOGI & CO., Ltd.
: The funding source had no role in the design, practice, or analysis of this study.